CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-11.76%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$300M
AUM Growth
+$300M
(-34%)
Cap. Flow
+$100K
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
Surrozen
SRZN
|
$97K |
| 2 |
RAPT Therapeutics
RAPT
|
$3.23K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $109M | 36.3% |
4,577,840
| – | – |
|
|
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $91M | 30.31% |
18,136,735
| – | – |
|
|
3
RAPT Therapeutics
RAPT
$188M
| $53.1M | 17.67% |
2,680,621
+163
| +0% | +$3.23K |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $21M | 7% |
3,568,181
| – | – |
|
5
Tenaya Therapeutics
TNYA
$184M
| $18.9M | 6.29% |
9,400,290
| – | – |
|
|
6
Surrozen
SRZN
$104M
| $5.48M | 1.82% |
9,414,795
+166,666
| +2% | +$97K |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $1.84M | 0.61% |
4,309,329
| – | – |
|